Morningstar

Paradigm Health Raises $78 Million Series B to Make Clinical Trials Part of Routine Care Across the U.S. and Globally

With its national network, AI-powered platform, and trial-design capabilities, Paradigm Health is the leading partner for biopharma companies and health systems working to make clinical research a ...
MarketWatch

Paradigm Health Raises $78 Million Series B to Make Clinical Trials Part of Routine Care Across the U.S. and Globally

The MarketWatch News Department was not involved in the creation of this content. COLUMBUS, Ohio and NEW YORK, Dec. 4, 2025 /PRNewswire/ -- Paradigm Health, the technology company rebuilding the ...